Evidence map›Paper›PMID 22232475›Full record

ArticleArchives of ophthalmology (Chicago, Ill. : 1960)2012

Multimodality diagnostic imaging in unilateral acute idiopathic maculopathy.

Cecilia S Jung, John F Payne, Chris S Bergstrom, Blaine E Cribbs, Jiong Yan, G Baker Hubbard, Timothy W Olsen, Steven Yeh

Abstract read
In one paragraph

Article in Archives of ophthalmology (Chicago, Ill. : 1960), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 5 citations in OpenAlex.

  1. Multi modal imaging of pediatric unilateral macular discoid lesions.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  2. Presumed bilateral acute idiopathic maculopathy in a pediatric patient.American journal of ophthalmology case reports · 2025
    Article
  3. Review
  4. Bilateral asynchronous acute idiopathic maculopathy with disease recurrence.American journal of ophthalmology case reports · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Acute idiopathic maculopathy after COVID-19 vaccination.American journal of ophthalmology case reports · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Incidental unilateral idiopathic maculopathy in children.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2020
    Article
  13. [Hand, foot and mouth disease-associated maculopathy: a 2-year course].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. A 24-year-old woman with sudden-onset, unilateral vision loss.Digital journal of ophthalmology : DJO · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cecilia S JungDepartment of Vitreoretinal Surgery and Disease, Emory University, Atlanta, Georgia, USA.
John F Payne
Chris S Bergstrom
Blaine E Cribbs
Jiong Yan
G Baker Hubbard
Timothy W Olsen
Steven Yeh
Emory Eye Center · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
NEI NIH HHS P30 EY 006360NEI NIH HHS P30 EY006360
6 · The paper itself

Abstract

objectiveTo describe the clinical features and imaging characteristics in unilateral acute idiopathic maculopathy.

methodsRetrospective review of 4 patients with a diagnosis of unilateral acute idiopathic maculopathy. Clinical characteristics (age, symptoms, Snellen visual acuity, and funduscopic features) and images from spectral-domain optical coherence tomography, fundus autofluorescence, fluorescein angiography, and indocyanine green angiography were analyzed.

resultsThe median (range) age at presentation was 31 (27-52) years. The median (range) interval between symptom onset and presentation was 4 (1-20) weeks. Associated systemic findings included a viral prodrome (50%), orchitis (50%), hand-foot-mouth disease (25%), and positive coxsackievirus titers (50%). The median (range) visual acuity at initial examination was 20/400 (20/70 to 1/400), which improved to 20/30 (20/20 to 20/60) at final follow-up. The median (range) follow-up time was 8 (8-13) weeks. Early in the disease course, the central macula developed irregular, circular areas of white-gray discoloration. Following recovery, the macula had a stippled retinal pigment epithelium characterized by rarefaction and hyperplasia. Fluorescein angiography demonstrated irregular early hyperfluorescence and late subretinal hyperfluorescence. Spectral-domain optical coherence tomography showed a partially reversible disruption of the outer photoreceptor layer. Fundus autofluorescence initially revealed stippled autofluorescence that eventually became more hypoautofluorescent. Indocyanine green angiography showed "moth-eaten"-appearing choroidal vasculature, suggestive of choroidal inflammation.

conclusionsThe imaging characteristics highlight the structural changes during the active and resolution phases of unilateral acute idiopathic maculopathy. The visual recovery correlates with structural changes and suggests that the pathogenesis involves inflammation of the inner choroid, retinal pigment epithelium, and outer photoreceptor complex that is partially reversible.

Indexed as

Fluorescein AngiographyIndocyanine GreenTomography, Optical CoherenceAcute DiseaseAdultChoroidElectroretinographyFemaleHumansMacula LuteaMaleMiddle AgedOphthalmoscopyRetinal DiseasesRetrospective StudiesVisual AcuityIndocyanine Green

Identifiers

PMID22232475
PMCPMC4116109
OpenAlexW963321470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.